Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1947 1
1948 2
1949 1
1951 2
1953 3
1954 2
1955 2
1956 3
1957 2
1958 6
1959 16
1960 19
1961 15
1962 19
1963 19
1964 15
1965 10
1966 10
1967 13
1968 21
1969 22
1970 28
1971 23
1972 24
1973 24
1974 20
1975 20
1976 19
1977 22
1978 17
1979 23
1980 24
1981 13
1982 14
1983 14
1984 23
1985 10
1986 12
1987 12
1988 14
1989 19
1990 16
1991 10
1992 16
1993 10
1994 11
1995 18
1996 25
1997 29
1998 23
1999 28
2000 28
2001 24
2002 14
2003 25
2004 33
2005 31
2006 27
2007 30
2008 32
2009 42
2010 37
2011 49
2012 30
2013 46
2014 59
2015 70
2016 49
2017 68
2018 84
2019 103
2020 115
2021 115
2022 106
2023 118
2024 73

Text availability

Article attribute

Article type

Publication date

Search Results

1,986 results

Results by year

Filters applied: . Clear all
Page 1
Impact of the motivational interviewing for childhood obesity treatment: The Obemat2.0 randomized clinical trial.
Luque V, Feliu A, Closa-Monasterolo R, Muñoz-Hernando J, Ferré N, Gutiérrez-Marín D, Guillen N, Basora J, Hsu P, Alegret-Basora C, Serrano MÀ, Mallafré M, Alejos AM, Balcells EN, Boada À, Paixà S, Mimbrero G, Gil-Mancha S, Tudela-Valls C, Alcazar M, Escribano J; Obemat2.0 Study Group. Luque V, et al. Pediatr Obes. 2024 May 11:e13125. doi: 10.1111/ijpo.13125. Online ahead of print. Pediatr Obes. 2024. PMID: 38733242
Methods for pragmatic randomized clinical trials of pain therapies: IMMPACT statement.
Hohenschurz-Schmidt D, Cherkin D, Rice ASC, Dworkin RH, Turk DC, McDermott MP, Bair MJ, DeBar LL, Edwards RR, Evans SR, Farrar JT, Kerns RD, Rowbotham MC, Wasan AD, Cowan P, Ferguson M, Freeman R, Gewandter JS, Gilron I, Grol-Prokopczyk H, Iyengar S, Kamp C, Karp BI, Kleykamp BA, Loeser JD, Mackey S, Malamut R, McNicol E, Patel KV, Schmader K, Simon L, Steiner DJ, Veasley C, Vollert J. Hohenschurz-Schmidt D, et al. Among authors: simon l. Pain. 2024 May 3. doi: 10.1097/j.pain.0000000000003249. Online ahead of print. Pain. 2024. PMID: 38723171
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial.
Coletta AM, Simon LH, Maslana K, Taylor S, Larson K, Hansen PA, Thomas VM, Ulrich CM, Kohli M, Chipman J, Swami U, Gupta S, Maughan BL, Agarwal N. Coletta AM, et al. Among authors: simon lh. BMC Cancer. 2024 Apr 18;24(1):493. doi: 10.1186/s12885-024-12260-3. BMC Cancer. 2024. PMID: 38637770 Free PMC article.
"I couldn't carry on taking a drug like that": A qualitative study of patient perspectives on side effects from rheumatology drugs.
Berthelsen DB, Nielsen SM, Rasmussen MU, Voshaar M, Richards P, Bartlett SJ, Hazlewood GS, Shea BJ, Tugwell P, Ellingsen T, Jørgensen TS, Kristensen S, Simon LS, Christensen R, Flurey CA; OMERACT Safety Working Group. Berthelsen DB, et al. Among authors: simon ls. Rheumatology (Oxford). 2024 Apr 13:keae223. doi: 10.1093/rheumatology/keae223. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38613847
1,986 results